Search

Natalia B Dyatkina

from San Mateo, CA
Age ~69
Get Report
Also known as:
Natalia T Dyatkina, Natalia D Dyatkina, Natalia B D Khorlin, Natalia B Khorin, Natalia B Khorlin, Natalia Dyatkin
Related to:
Andrey Khorlin, 55Andrey A Khorlin, 44Alexander A Khorlin, 70Nickolay Khorlin, 36Alexander A Khorlin
Connected to:
Jennifer Dyba, 34Joseph Dyba, 70Steven A Dyba, 41Mark C Dybal, 65Vivien Dybal, 63Beth E Dybala, 54Daniel Dybala, 82Eugene M Dybala, 72Jared P Dybala, 44Brandi R Dyball, 42

Natalia Dyatkina Phones & Addresses

  • San Mateo, CA
  • 150 Pacchetti Way, Mountain View, CA 94040
  • 1976 Cherrywood St, Vista, CA 92083 (760) 598-7066
  • Redwood City, CA
  • College Park, MD
  • North Potomac, MD
  • Rockville, MD
  • Germantown, MD
  • Santa Clara, CA

Education

Degree: High school graduate or higher

Resumes

Resumes

Natalia Dyatkina Photo 1

Principal Scientist

View page
Location:
San Francisco, CA
Industry:
Biotechnology
Work:
Alios Bioparma
Principal Scientist
Genelabs Technologies Jan 1999 - Mar 2009
Senior Scientist
Codon Pharmaceuticals Sep 1996 - Sep 1998
Scientist
Institute For Molecular Biology Russian Academy of Sciences Dec 1991 - Aug 1996
Senior Scientist
Institute of Molecular Biology Russian Academy of Science 1978 - 1996
Senior Scientist
Education:
Institute For Molecular Biology, Russian Academy of Sciences 1981 - 1985
Lomonosov Institute For Fine Chemical Technology 1972 - 1978
Master of Science, Masters, Chemistry
Skills:
Purification
Organic Synthesis
Hplc
Lead Optimization
Interests:
Nucleotides and Triphosphates
Chemisty of Nucleic Acids Components
Carbohydrates
Heterocyclic Bases
Synthetic Organic Chemistry
Synthesis of Nucleosides
Natalia Dyatkina Photo 2

Senior Scientist At Alios Bioparma

View page
Position:
Principal Scientist at Alios BioParma
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Alios BioParma since Aug 2009
Principal Scientist
Genelabs Technologies Jan 1999 - Mar 2009
Senior Scientist
Codon Pharmaceuticals Sep 1996 - Sep 1998
Scientist
Institute for Molecular Biology, Russian Academy of Sciences Dec 1991 - Aug 1996
Senior Scientist
Institute of Molecular Biology, Russian Academy of Science 1978 - 1996
Senior Scientist
Education:
Institute for Molecular Biology, Russian Academy of Sciences 1981 - 1985
Ph. D, Bioorganic Chemistry Lomonosov Institute for Fine Chemical Technology 1972 - 1978
MS, Bioorganic Chemistry
Skills:
Lead Optimization
Purification
Organic Synthesis
HPLC
Interests:
Synthetic organic chemistry. Chemisty of Nucleic Acids components: carbohydrates, heterocyclic bases. Synthesis of nucleosides, nucleotides and triphosphates.

Publications

Us Patents

Compounds Possessing Antibacterial, Antifungal Or Antitumor Activity

View page
US Patent:
6906103, Jun 14, 2005
Filed:
Oct 23, 2002
Appl. No.:
10/277666
Inventors:
Wentao Zhang - Foster City CA, US
Sebastian Johannes Reinhard Liehr - East Palo Alto CA, US
Mark Douglas Velligan - Montara CA, US
Natalia B. Dyatkina - Mountain View CA, US
Janos Botyanszki - Cupertino CA, US
Dong-Fang Shi - San Mateo CA, US
Christopher Don Roberts - Belmont CA, US
Alexander Khorlin - Mountain View CA, US
Peter Harold Nelson - Los Altos CA, US
Joseph Martin Muchowski - Sunnyvale CA, US
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
A61K031/13
US Classification:
514579
Abstract:
The present invention provides novel compounds possessing one or more of the following activities: antibacterial, antifungal and antitumor activity. The compounds are of Formula (I): Pharmaceutical compositions containing these compounds, methods of making and methods for using these compounds are also provided.

Aromatic Compounds And Poly(Oxyalkylene) Containing Aromatic Compounds Possessing Antibacterial, Antifungal Or Antitumor Activity

View page
US Patent:
7064218, Jun 20, 2006
Filed:
Dec 24, 2002
Appl. No.:
10/328710
Inventors:
Natalia B. Dyatkina - Mountain View CA, US
Dong-Fang Shi - Fremont CA, US
Christopher Don Roberts - Belmont CA, US
Mark Douglas Velligan - Montara CA, US
Sebastian Johannes Reinhard Liehr - East Palo Alto CA, US
Janos Botyanszki - Fremont CA, US
Wentao Zhang - Foster City CA, US
Alexander Khorlin - Mountain View CA, US
Peter Harold Nelson - Los Altos CA, US
Joseph Martin Muchowski - Sunnyvale CA, US
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
C07D 207/00
C07D 207/10
A01N 43/64
A61K 31/40
US Classification:
548400, 548541, 548557, 514359, 514408
Abstract:
The present invention provides novel compounds possessing one or more of the following activities: antibacterial, antifungal and antitumor activity. The compounds are of Formula (I):.

Nucleoside Derivatives For Treating Hepatitis C Virus Infection

View page
US Patent:
7094768, Aug 22, 2006
Filed:
Apr 8, 2004
Appl. No.:
10/821638
Inventors:
Christopher D. Roberts - Belmont CA, US
Jesse Keicher - Menlo Park CA, US
Natalia B. Dyatkina - Mountain View CA, US
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
A61K 31/70
C07H 19/14
C07H 19/20
US Classification:
514 45, 536 2623, 536 2626, 536 267, 536 272
Abstract:
Disclosed are 6-hydroxyamino- or a 6-alkoxyamino-7-deazapurine-ribofuranose derivatives, salts, pharmaceutical compositions, and methods of use thereof for treating viral infections caused by a flaviviridae family virus, such as hepatitis C virus.

Nucleoside Compounds For Treating Viral Infections

View page
US Patent:
7157434, Jan 2, 2007
Filed:
Oct 20, 2004
Appl. No.:
10/970321
Inventors:
Jesse D. Keicher - Menlo Park CA, US
Christopher D. Roberts - Belmont CA, US
Natalia B. Dyatkina - Mountain View CA, US
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
A61K 31/70
C07H 19/14
US Classification:
514 43, 536 2623, 536 2626, 536 267, 536 272
Abstract:
Disclosed are compounds, compositions and methods for treating viral infections caused by a flaviviridae family virus, such as hepatitis C virus. Such compounds are represented by Formula I as follows:.

Methods For Preparing 7-(2′-Substituted-Β-D-Ribofuranosyl)-4-(Nrr)-5-(Substituted Ethyn-1-Yl)-Pyrrolo[2,3-D]Pyrimidine Derivatives

View page
US Patent:
7169918, Jan 30, 2007
Filed:
Oct 20, 2004
Appl. No.:
10/970641
Inventors:
Christopher D. Roberts - Belmont CA, US
Jesse D. Keicher - Menlo Park CA, US
Natalia B. Dyatkina - Mountain View CA, US
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
C07H 19/14
C07D 487/02
US Classification:
536 272, 548453
Abstract:
Disclosed are methods and intermediates for the preparation of 7-(2′-R-substituted-β-D-ribofuranosyl)-4-amino-5-(optionally substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine compounds. These compounds are useful in treating viral infections caused by a family virus, such as hepatitis C virus. Such 7-(2′-substituted-β-D-ribofuranosyl)-4-amino-5-(optionally substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine compounds are represented by Formula I as follows:.

Nucleoside Compounds For Treating Viral Infections

View page
US Patent:
7244713, Jul 17, 2007
Filed:
Oct 21, 2004
Appl. No.:
10/971477
Inventors:
Christopher D. Roberts - Belmont CA, US
Jesse D. Keicher - Menlo Park CA, US
Natalia B. Dyatkina - Mountain View CA, US
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
A61K 31/70
C07H 19/14
US Classification:
514 43, 536 2623, 536 2626, 536 267, 536 272
Abstract:
Disclosed are compounds, compositions and methods for treating viral infections caused by a flaviviridae family virus, such as hepatitis C virus. Such compounds are represented by Formula I as follows:.

Nucleoside Compounds For Treating Viral Infections

View page
US Patent:
7405204, Jul 29, 2008
Filed:
Apr 25, 2006
Appl. No.:
11/411434
Inventors:
Christopher D. Roberts - Belmont CA, US
Ronald Conrad Griffith - Escondido CA, US
Natalia B. Dyatkina - Mountain View CA, US
Marija Prhavc - Encinitas CA, US
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
A01N 43/04
A61K 31/70
C07H 19/00
C07H 19/04
US Classification:
514 42, 514 43, 514 52, 536 221, 536 261, 536 271, 536 272
Abstract:
Disclosed are compounds, compositions and methods for treating viral infections caused by a Flaviviridae family virus, such as hepatitis C virus.

5-Nitro-Nucleoside Compounds For Treating Viral Infections

View page
US Patent:
7414031, Aug 19, 2008
Filed:
Nov 15, 2005
Appl. No.:
11/280984
Inventors:
Jesse D. Keicher - Menlo Park CA, US
Christopher D. Roberts - Belmont CA, US
Natalia B. Dyatkina - Mountain View CA, US
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
A61K 31/70
C07H 19/14
US Classification:
514 43, 536 2623, 536 2626, 536 267, 536 272
Abstract:
Disclosed are compounds, compositions and methods for treating viral infections caused by a flaviviridae family virus, such as hepatitis C virus.
Control profile
Natalia B Dyatkina from San Mateo, CA, age ~69 Get Report